Mineralys Therapeutics, Inc. SEC filings MLYS
Mineralys Therapeutics, Inc. has 408 filings in SEC EDGAR's recent list, going back to Jun 13, 2022. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jun 3, 2026 | — |
| S-8 | Employee stock plan registration | Feb 13, 2026 | — |
| S-3ASR | Automatic shelf registration | Nov 10, 2025 | — |
| 424B5 | Prospectus supplement | Sep 3, 2025 | — |
| S-3MEF | Filing | Sep 2, 2025 | — |
| 424B5 | Prospectus supplement | Sep 2, 2025 | — |
| 424B5 | Prospectus supplement | Mar 12, 2025 | — |
| 424B5 | Prospectus supplement | Mar 10, 2025 | — |
| S-8 | Employee stock plan registration | Feb 14, 2025 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| 424B5 | Prospectus supplement | Apr 11, 2024 | — |
| S-3/A | Filing | Mar 29, 2024 | — |
| S-3 | Shelf registration | Mar 21, 2024 | — |
| S-8 | Employee stock plan registration | Feb 10, 2023 | — |
| 424B4 | Prospectus | Feb 10, 2023 | — |
| S-1MEF | Filing | Feb 9, 2023 | — |
| S-1/A | Amended registration statement | Feb 2, 2023 | — |
| S-1 | Registration statement | Jan 18, 2023 | — |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MLYS (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Radnor, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1933414
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.